Tuesday, August 01, 2017 10:44:48 AM
Bignitz, which you can do as well, AND made the email public that the phase 1 study had technical difficulties and is in process. (Smallville-He didnt say needs to be redone )Any further q's i asked was met with silence. You laugh and try to dismiss it, so that you can ignore it. That to me is ignorance. You scoffing the company wouldn't email a few private ppl information is silly. It is not like they reached out to me. i guess they were not looking to share bad news publicly. THAT is the
primary complaint about them. Which causes people to doubt and to sell. And THAT partially why the price is where it is at with no bottom. I'm looking forward to hearing what email response you get from bignitz or whomever you decide to email, because I'm sure you are also wondering why the info on clinicaltrials.gov says the completion date of July. There is also a number on there that you might try calling. Keep us posted
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM